Bausch + Lomb Corporation (S2L)
FSX
Closed
Aug 25, 2026
Day's Range
14.6052 wk Range
12.00Overview - S2L - Bausch + Lomb Corporation
Key Statistics
Valuation
Enterprise Value
8.53B
P/E (Trailing)
‪-14.21‬
PEG Ratio
‪0.18‬
Price / Sales (TTM)
‪0.97‬
Price / Book
‪0.92‬
EV / EBITDA
‪12.24‬
Profitability
Gross Margin
‪62.19%‬
Profit Margin
‪-3.21%‬
Operating Margin
‪7.74%‬
Return on Assets
‪1.82%‬
Return on Equity
‪-2.51%‬
Ownership
Shares Outstanding
357.05M
Float
45.30M
Held by Insiders
‪87.34%‬
Held by Institutions
‪11.14%‬
Price stats
Beta
‪0.55‬
50-Day Avg
‪14.18‬
200-Day Avg
‪14.00‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - S2L - Bausch + Lomb Corporation
Peers - S2L - Bausch + Lomb Corporation
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on FSX.
Profile Summary - S2L - Bausch + Lomb Corporation
About
Bausch + Lomb Corporation, a leading health care company, primarily focuses on eye health products. The corporation specializes in the development, manufacture, and marketing of a comprehensive range of contact lenses, lens care products, ophthalmic pharmaceuticals, and surgical devices, all designed to improve sight…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
